[November 27, 2015] |
|
Research and Markets: Global Lung Cancer Pipeline Review 2015
Research and Markets (http://www.researchandmarkets.com/research/737n6x/lung_cancer)
has announced the addition of the "Lung
Cancer - Pipeline Review, 2015" report to their offering.
The report provides comprehensive information on the pipeline products
with comparative analysis of the products at various stages of
development. The report reviews major players involved in the pipeline
product development. It also provides information about clinical trials
in progress, which includes trial phase, trial status, trial start and
end dates, and, the number of trials for the key Lung Cancer diagnostic
tests pipeline products.
Scope
-
Extensive coverage of the Lung Cancer diagnostic tests under
development
-
The report reviews details of major pipeline products which includes,
product description, licensing and collaboration details and other
developmental activities
-
The report reviews the major players involved in the development of
Lung Cancer diagnostic tests and list all their pipeline projects
-
The coveage of pipeline products based on various stages of
development ranging from Early Development to Approved / Issued stage
-
The report provides key clinical trial data of ongoing trials specific
to pipeline products
-
Recent developments in the segment / industry
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Products under Development
4 Lung Cancer - Pipeline Products under Development by Companies
5 Lung Cancer Companies and Product Overview
6 Lung Cancer- Recent Developments
7 Appendix
Companies Mentioned - 35 of the 100+ Companies
-
A&G Pharmaceutical, Inc.
-
Advpharma Inc.
-
Ceres Nanosciences, Inc.
-
Cernostics Inc.
-
ChemImage Corporation
-
Chronix Biomedical, Inc.
-
Clarient, Inc.
-
GenomicTree, Inc.
-
GILUPI Nanomedizin
-
Global Discovery Biosciences
-
GlycoZym
-
HTG Molecular Diagnostics, Inc.
-
ImmunoCellular Therapeutics, Ltd.
-
Insight Genetics, Inc.
-
MolecularMD, Corp.
-
Nanopore Diagnostics, LLC
-
Neogenix Oncology, Inc.
-
NEOMICS Co., Ltd.
-
Novel Bio-spectrum Technologies, Inc.
-
Nuvera Biosciences, Inc.
-
Oncolome Diagnostics Inc.
-
Onconome, Inc.
-
OPKO Health, Inc.
-
Orion Genomics LLC
-
OTraces Inc.
-
Oxford Gene Technology Limited
-
PeriRx LLC
-
US Biomarkers, Inc.
-
Ventana Medical Systems, Inc.
-
Veracyte, Inc.
-
Vigilant Biosciences, Inc.
-
Viomics Inc.
-
VisionGate, Inc.
-
Vitatex Inc.
-
VolitionRX Ltd.
For more information visit http://www.researchandmarkets.com/research/737n6x/lung_cancer
View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005266/en/
[ Back To TMCnet.com's Homepage ]
|